Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Article in English | MEDLINE | ID: mdl-23083414

ABSTRACT

Glycidyl esters (GEs) are known to be formed during vegetable oil processing. Because of their structure, it has been hypothesised that GEs, like fatty acid esters of chloropropanols (MCPD esters), may be accepted as substrates by gut lipases to release the epoxide glycidol. If confirmed such a hypothesis would be important for risk assessment since glycidol is considered as a genotoxic carcinogen. In the present study, biotransformation was investigated using static and dynamic gastrointestinal models. During the experiments, aliquots were analysed for non-digested GEs using liquid chromatography-time-of-flight-mass spectrometry (LC-ToF-MS). In the static model, a fast hydrolysis of GEs was observed as a result of lipase action. Lipase was very efficient at pH 4.8, and totally inhibited at very low pH (1.7). In the absence of lipase, GEs were found to be relatively stable. The potential impact of food matrix was studied using milk in a dynamic model simulating human physiological conditions. The fast, pH-dependent hydrolysis of GEs was further confirmed. The possible transformation of the digestion products was then investigated using gas chromatography coupled to mass spectrometry (GC-MS), mainly the epoxide ring-opening to glycerol followed by additional reactions. In any conditions applied, neither 2- nor 3-mono-chloropropanediol (2- nor 3-MCPD) were formed, indicating that a ring-opening of the epoxide group of GEs or glycidol followed by a reaction with chloride was unlikely. A small transformation of glycidol into glycerol was observed after longer incubation time correlated with a low pH. This suggested that ring-opening and reaction with water is possible in strongly acidic conditions. Overall, it is concluded that GEs are rapidly digested by gut lipases to form glycidol. Consequently, GEs should be considered as sources of glycidol exposure. In addition, risk assessment of GEs can likely rely on hazard identification and characterisation data specific for glycidol.


Subject(s)
Dietary Fats, Unsaturated/analysis , Digestion/physiology , Glycerides/chemistry , Models, Biological , Plant Oils/chemistry , Chromatography, Liquid/methods , Electrolytes , Epoxy Compounds/chemistry , Epoxy Compounds/metabolism , Esters , Fatty Acids , Food Contamination , Food Handling , Humans , Lipase/metabolism , Mass Spectrometry/methods , Molecular Structure , Propanols/chemistry , Propanols/metabolism
2.
J Toxicol ; 2011: 645361, 2011.
Article in English | MEDLINE | ID: mdl-21776264

ABSTRACT

The in vitro and in vivo evidence compatible with a role for oxidative stress in OTA carcinogenicity has been collected and described. Several potential oxido-reduction mechanisms have been identified in the past. More recently, the possibility of a reduction of cellular antioxidant defense has been raised as an indirect source of oxidative stress. Consequences resulting from the production of oxidative stress are observed at different levels. First, OTA exposure has been associated with increased levels of oxidative DNA, lipid, and protein damage. Second, various biological processes known to be mobilized under oxidative stress were shown to be altered by OTA. These effects have been observed in both in vitro and in vivo test systems. In vivo, active doses were often within doses documented to induce renal tumors in rats. In conclusion, the evidence for the induction of an oxidative stress response resulting from OTA exposure can be considered strong. Because the contribution of the oxidative stress response in the development of cancers is well established, a role in OTA carcinogenicity is plausible. Altogether, the data reviewed above support the application of a threshold-based approach to establish safe level of dietary human exposure to OTA.

3.
Toxicol Appl Pharmacol ; 245(2): 179-90, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20226806

ABSTRACT

Estragole is a natural constituent of several herbs and spices including sweet basil. In rodent bioassays, estragole induces hepatomas, an effect ascribed to estragole bioactivation to 1'-sulfooxyestragole resulting in DNA adduct formation. The present paper identifies nevadensin as a basil constituent able to inhibit DNA adduct formation in rat hepatocytes exposed to the proximate carcinogen 1'-hydroxyestragole and nevadensin. This inhibition occurs at the level of sulfotransferase (SULT)-mediated bioactivation of 1'-hydroxyestragole. The Ki for SULT inhibition by nevadensin was 4 nM in male rat and human liver fractions. Furthermore, nevadensin up to 20 microM did not inhibit 1'-hydroxyestragole detoxification by glucuronidation and oxidation. The inhibition of SULT by nevadensin was incorporated into the recently developed physiologically based biokinetic (PBBK) rat and human models for estragole bioactivation and detoxification. The results predict that co-administration of estragole at a level inducing hepatic tumors in vivo (50mg/kg bw) with nevadensin at a molar ratio of 0.06, representing the ratio of their occurrence in basil, results in almost 100% inhibition of the ultimate carcinogen 1'-sulfooxyestragole when assuming 100% uptake of nevadensin. Assuming 1% uptake, inhibition would still amount to more than 83%. Altogether these data point at a nevadensin-mediated inhibition of the formation of the ultimate carcinogenic metabolite of estragole, without reducing the capacity to detoxify 1'-hydroxyestragole via glucuronidation or oxidation. These data also point at a potential reduction of the cancer risk when estragole exposure occurs within a food matrix containing SULT inhibitors compared to what is observed upon exposure to pure estragole.


Subject(s)
Anisoles/pharmacokinetics , Carcinogens/pharmacokinetics , Flavones/pharmacology , Ocimum basilicum , Sulfotransferases/antagonists & inhibitors , Allylbenzene Derivatives , Animals , Anisoles/metabolism , DNA Adducts/metabolism , Dose-Response Relationship, Drug , Glucuronides/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , In Vitro Techniques , Male , Models, Biological , Oxidation-Reduction , Plant Extracts , Rats , Rats, Sprague-Dawley , Toxicity Tests, Acute
4.
Article in English | MEDLINE | ID: mdl-19412856

ABSTRACT

Mutagenicity and carcinogenicity are endpoints of major environmental and regulatory concern. These endpoints are also important targets for development of alternative methods for screening and prediction due to the large number of chemicals of potential concern and the tremendous cost (in time, money, animals) of rodent carcinogenicity bioassays. Both mutagenicity and carcinogenicity involve complex, cellular processes that are only partially understood. Advances in technologies and generation of new data will permit a much deeper understanding. In silico methods for predicting mutagenicity and rodent carcinogenicity based on chemical structural features, along with current mutagenicity and carcinogenicity data sets, have performed well for local prediction (i.e., within specific chemical classes), but are less successful for global prediction (i.e., for a broad range of chemicals). The predictivity of in silico methods can be improved by improving the quality of the data base and endpoints used for modelling. In particular, in vitro assays for clastogenicity need to be improved to reduce false positives (relative to rodent carcinogenicity) and to detect compounds that do not interact directly with DNA or have epigenetic activities. New assays emerging to complement or replace some of the standard assays include Vitotox, GreenScreenGC, and RadarScreen. The needs of industry and regulators to assess thousands of compounds necessitate the development of high-throughput assays combined with innovative data-mining and in silico methods. Various initiatives in this regard have begun, including CAESAR, OSIRIS, CHEMOMENTUM, CHEMPREDICT, OpenTox, EPAA, and ToxCast. In silico methods can be used for priority setting, mechanistic studies, and to estimate potency. Ultimately, such efforts should lead to improvements in application of in silico methods for predicting carcinogenicity to assist industry and regulators and to enhance protection of public health.


Subject(s)
Carcinogens/toxicity , Models, Biological , Models, Chemical , Mutagens/toxicity , Quantitative Structure-Activity Relationship , Animals , Carcinogens/chemistry , Expert Systems , Forecasting/methods , Humans , Mutagens/chemistry , Risk Assessment , Rodentia
5.
Food Chem Toxicol ; 46(4): 1239-48, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17976884

ABSTRACT

Coffee consumption has been associated with a significant decrease in the risk of developing chronic diseases such as Parkinson disease, diabetes type-2 and several types of cancers (e.g. colon, liver). In the present study, a coffee-dependent induction of enzymes involved in xenobiotic detoxification processes was observed in rat liver and primary hepatocytes. In addition, coffee was found to induce the mRNA and protein expression of enzymes involved in cellular antioxidant defenses. These inductions were correlated with the activation of the Nrf2 transcription factor as shown using an ARE-reporter luciferase assay. The induction of detoxifying enzymes GSTs and AKR is compatible with a protection against both genotoxicity and cytotoxicity of aflatoxin B1 (AFB1). This hypothesis was confirmed in in vitro and ex vivo test systems, where coffee reduced both AFB1-DNA and protein adducts. Interestingly, coffee was also found to inhibit cytochrome CYP1A1/2, indicating that other mechanisms different from a stimulation of detoxification may also play a significant role in the chemoprotective effects of coffee. Further investigations in either human liver cell line and primary hepatocytes indicated that the chemoprotective effects of coffee against AFB1 genotoxicity are likely to be of relevance for humans. These data strongly suggest that coffee may protect against the adverse effects of AFB1. In addition, the coffee-mediated stimulation of the Nrf2-ARE pathway resulting in increased endogenous defense mechanisms against electrophilic but also oxidative insults further support that coffee may be associated with a protection against various types of chemical stresses.


Subject(s)
Anticarcinogenic Agents/pharmacology , Coffee/chemistry , Liver Neoplasms, Experimental/prevention & control , NF-E2-Related Factor 2/biosynthesis , Aflatoxin B1/toxicity , Animals , Antioxidants/metabolism , Blotting, Western , Carcinogens/toxicity , Cytochrome P-450 CYP1A1/metabolism , Cytochrome P-450 CYP1A2/metabolism , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/metabolism , Dose-Response Relationship, Drug , Genes, Reporter , Glutathione/metabolism , Glutathione Transferase/metabolism , Hepatocytes/drug effects , Hepatocytes/enzymology , Hepatocytes/pathology , Humans , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/enzymology , Luciferases/metabolism , Male , Rats , Rats, Sprague-Dawley , Regulatory Elements, Transcriptional , Reverse Transcriptase Polymerase Chain Reaction
6.
Toxicol Appl Pharmacol ; 224(2): 174-81, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17651772

ABSTRACT

Kidney samples of male Fischer 344 (F-344) rats fed a carcinogenic dose of OTA over 7 days, 21 days and 12 months were analysed for various cell signalling proteins known to be potentially involved in chemical carcinogenicity. OTA was found to increase the phosphorylation of atypical-PKC. This was correlated with a selective downstream activation of the MAP-kinase extracellular regulated kinases isoforms 1 and 2 (ERK1/2) and of their substrates ELK1/2 and p90RSK. Moreover, analysis of effectors acting upstream of PKC indicated a possible mobilisation of the insulin-like growth factor-1 receptor (lGFr) and phosphoinositide-dependent kinase-1 (PDK1) system. An increased histone deacetylase (HDAC) enzymatic activity associated with enhanced HDAC3 protein expression was also observed. These findings are potentially relevant with respect to the understanding of OTA nephrocarcinogenicity. HDAC-induced gene silencing has previously been shown to play a role in tumour development. Furthermore, PKC and the MEK-ERK MAP-kinase pathways are known to play important roles in cell proliferation, cell survival, anti-apoptotic activity and renal cancer development.


Subject(s)
Carcinogens/toxicity , Mitogen-Activated Protein Kinase 1/drug effects , Mitogen-Activated Protein Kinase 3/drug effects , Ochratoxins/toxicity , 3-Phosphoinositide-Dependent Protein Kinases , Animals , Blotting, Western , Carcinogens/administration & dosage , Gene Expression Regulation/drug effects , Histone Deacetylases/metabolism , Kidney/metabolism , Kidney Neoplasms/chemically induced , Kidney Neoplasms/physiopathology , MAP Kinase Signaling System/drug effects , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Ochratoxins/administration & dosage , Phosphorylation , Protein Serine-Threonine Kinases/drug effects , Protein Serine-Threonine Kinases/metabolism , Rats , Rats, Inbred F344 , Receptor, IGF Type 1/drug effects , Receptor, IGF Type 1/metabolism , Ribosomal Protein S6 Kinases, 90-kDa/drug effects , Ribosomal Protein S6 Kinases, 90-kDa/metabolism , Time Factors , ets-Domain Protein Elk-1/drug effects , ets-Domain Protein Elk-1/metabolism
7.
Toxicol Sci ; 89(1): 120-34, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16251485

ABSTRACT

Ochratoxin A (OTA) is a mycotoxin occurring naturally in a wide range of food commodities. In animals, it has been shown to cause a variety of adverse effects, nephrocarcinogenicity being the most prominent. Because of its high toxic potency and the continuous exposure of the human population, OTA has raised public health concerns. There is significant debate on how to use the rat carcinogenicity data to assess the potential risk to humans. In this context, the question of the mechanism of action of OTA appears of key importance and was studied through the application of a toxicogenomics approach. Male Fischer rats were fed OTA for up to 2 years. Renal tumors were discovered during the last 6 months of the study. The total tumor incidence reached 25% at the end of the study. Gene expression profile was analyzed in groups of animals taken in intervals from 7 days to 12 months. Tissue-specific responses were observed in kidney versus liver. For selected genes, microarray data were confirmed at both mRNA and protein levels. In kidney, several genes known as markers of kidney injury and cell regeneration were significantly modulated by OTA. The expression of genes known to be involved in DNA synthesis and repair, or genes induced as a result of DNA damage, was only marginally modulated. Very little or no effect was found amongst genes associated with apoptosis. Alterations of gene expression indicating effects on calcium homeostasis and a disruption of pathways regulated by the transcription factors hepatocyte nuclear factor 4 alpha (HNF4alpha) and nuclear factor-erythroid 2-related factor 2 (Nrf2) were observed in the kidney but not in the liver. Previous data have suggested that a reduction in HNF4alpha may be associated with nephrocarcinogenicity. Many Nrf2-regulated genes are involved in chemical detoxication and antioxidant defense. The depletion of these genes is likely to impair the defense potential of the cells, resulting in chronic elevation of oxidative stress in the kidney. The inhibition of defense mechanism appears as a highly plausible new mechanism, which could contribute to OTA carcinogenicity.


Subject(s)
Carcinogens/toxicity , Epigenesis, Genetic , Gene Expression Profiling , Kidney Neoplasms/chemically induced , Mycotoxins/toxicity , Ochratoxins/toxicity , Administration, Oral , Animals , Biomarkers , Gene Expression Regulation, Neoplastic/drug effects , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Rats , Rats, Inbred F344 , Toxicogenetics
8.
Biochem Biophys Res Commun ; 327(3): 742-9, 2005 Feb 18.
Article in English | MEDLINE | ID: mdl-15649409

ABSTRACT

Chicory is a major source of fructans with reported prebiotic-bifidogenic properties. In the present study, the potential anti-inflammatory activities of chicory were investigated. Ethyl acetate chicory root extract produced a marked inhibition of prostaglandin E(2) (PGE(2)) production in human colon carcinoma HT29 cells treated with the pro-inflammatory agent TNF-alpha. Two independent mechanisms of action were identified: (1) a drastic inhibition of the induction by TNF-alpha of cyclooxygenase 2 (COX-2) protein expression and (2) a direct inhibition of COX enzyme activities with a significantly higher selectivity for COX-2 activity. The inhibition of TNF-alpha-dependent induction of COX-2 expression was mediated by an inhibition of NF-kappaB activation. A major sesquiterpene lactone of chicory root, the guaianolide 8-deoxylactucin, was identified as the key inhibitor of COX-2 protein expression present in chicory extract. Altogether, the data presented strongly support chicory root as a promising source of functional food ingredient, combining prebiotic and anti-inflammatory properties.


Subject(s)
Cichorium intybus/chemistry , Enzyme Inhibitors/pharmacology , Intestinal Mucosa/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Anti-Inflammatory Agents/pharmacology , Cyclooxygenase 2 , Dose-Response Relationship, Drug , Gene Expression Regulation, Enzymologic/drug effects , HT29 Cells/drug effects , Humans , Intestinal Mucosa/cytology , Lactones/chemistry , Lactones/pharmacology , Membrane Proteins , NF-kappa B/metabolism , Plant Extracts/pharmacology , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Time Factors , Tumor Necrosis Factor-alpha/pharmacology
9.
Toxicol Appl Pharmacol ; 201(2): 97-104, 2004 Dec 01.
Article in English | MEDLINE | ID: mdl-15541749

ABSTRACT

An in vitro model, the aggregating brain cell culture of fetal rat telencephalon, has been used to investigate the influence of glial cells on the neurotoxicity of two organophosphorus pesticides (OPs), chlorpyrifos and parathion. Mixed-cell aggregate cultures were treated continuously for 10 days between DIV 5 and 15. Parathion induced astrogliosis at concentration at which MAP-2 immunostaining, found here to be more sensitive than neuron-specific enzyme activities, was not affected. In contrast, chlorpyrifos induced a comparatively weak gliotic reaction, and only at concentrations at which neurons were already affected. After similar treatments, increased neurotoxicity of parathion and chlorpyrifos was found in aggregate cultures deprived of glial cells. These results suggest that glial cells provide neuroprotection against OPs toxicity. To address the question of the difference in toxicity between parathion and chlorpyrifos, the toxic effects of their leaving groups, p-nitrophenol and trichloropyridinol, were studied in mixed-cell aggregates. General cytotoxicity was more pronounced for trichloropyridinol and both compounds had similar toxic effects on neuron-specific enzyme activities. In contrast, trichloropyridinol induced a much stronger decrease in glutamine synthetase activity, the enzymatic marker of astrocytes. Trichloropyridinol may exert a toxic effect on astrocytes, compromising their neuroprotective function, thus exacerbating the neurotoxicity of chlorpyrifos. This is in line with the suggestion that glial cells may contribute to OPs neurotoxicity, and with the view that OPs may exert their neurotoxic effects through different mechanisms.


Subject(s)
Chlorpyrifos/analogs & derivatives , Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Insecticides/toxicity , Neuroglia/pathology , Neurotoxicity Syndromes/pathology , Parathion/toxicity , Acetylcholinesterase/metabolism , Animals , Astrocytes/pathology , Brain/cytology , Cells, Cultured , Chlorpyrifos/metabolism , Choline O-Acetyltransferase/metabolism , Glutamate Decarboxylase/metabolism , Glutamate-Ammonia Ligase/metabolism , Immunohistochemistry , L-Lactate Dehydrogenase/metabolism , Paraoxon/metabolism , Paraoxon/toxicity , Protein Binding , Rats
10.
Food Chem Toxicol ; 42(1): 65-83, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14630131

ABSTRACT

The threshold of toxicological concern (TTC) is a pragmatic risk assessment tool that is based on the principle of establishing a human exposure threshold value for all chemicals, below which there is a very low probability of an appreciable risk to human health. The concept that there are levels of exposure that do not cause adverse effects is inherent in setting acceptable daily intakes (ADIs) for chemicals with known toxicological profiles. The TTC principle extends this concept by proposing that a de minimis value can be identified for many chemicals, in the absence of a full toxicity database, based on their chemical structures and the known toxicity of chemicals which share similar structural characteristics. The establishment and application of widely accepted TTC values would benefit consumers, industry and regulators. By avoiding unnecessary toxicity testing and safety evaluations when human intakes are below such a threshold, application of the TTC approach would focus limited resources of time, cost, animal use and expertise on the testing and evaluation of substances with the greatest potential to pose risks to human health and thereby contribute to a reduction in the use of animals. An Expert Group of the European branch of the International Life Sciences Institute-ILSI Europe-has examined the TTC principle for its wider applicability in food safety evaluation. The Expert Group examined metabolism and accumulation, structural alerts, endocrine disrupting chemicals and specific endpoints, such as neurotoxicity, teratogenicity, developmental toxicity, allergenicity and immunotoxicity, and determined whether such properties or endpoints had to be taken into consideration specifically in a step-wise approach. The Expert Group concluded that the TTC principle can be applied for low concentrations in food of chemicals that lack toxicity data, provided that there is a sound intake estimate. The use of a decision tree to apply the TTC principle is proposed, and this paper describes the step-wise process in detail. Proteins, heavy metals and polyhalogenated-dibenzodioxins and related compounds were excluded from this approach. When assessing a chemical, a review of prior knowledge and context of use should always precede the use of the TTC decision tree. The initial step is the identification and evaluation of possible genotoxic and/or high potency carcinogens. Following this step, non-genotoxic substances are evaluated in a sequence of steps related to the concerns that would be associated with increasing intakes. For organophosphates a TTC of 18microg per person per day (0.3 microg/kg bw/day) is proposed, and when the compound is not an OP, the TTC values for the Cramer structural classes III, II and I, with their respective TTC levels (e.g. 1800, 540 and 90 microg per person per day; or 30, 9 and 1.5 microg/kg bw /day), would be applied sequentially. All other endpoints or properties were shown to have a distribution of no observed effect levels (NOELs) similar to the distribution of NOELs for general toxicity endpoints in Cramer classes I, II and III. The document was discussed with a wider audience during a workshop held in March 2003 (see list of workshop participants).


Subject(s)
Diet , Food/toxicity , Structure-Activity Relationship , Animals , Carcinogens/toxicity , Decision Trees , Endocrine Glands/drug effects , Food Hypersensitivity , Humans , Metabolism , No-Observed-Adverse-Effect Level , Pharmacokinetics , Risk Assessment
11.
Food Chem Toxicol ; 41(12): 1625-49, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14563389

ABSTRACT

There is a growing interest by both consumers and industry for the development of food products with 'functional' properties, or health benefits. These products may take the form of dietary supplements or of foods. The health benefits are given by particular ingredients, and in many cases these are derived from botanicals. The variety of plants providing these functions is large, ranging from staple food sources such as cereals, fruits and vegetables, to herbals as used in traditional medicine. The food or ingredient conferring health properties may consist of the plants themselves, extracts thereof, or more purified components. The scientific literature is abundant with articles not only on the beneficial properties, but also on possible adverse health effects of plants and their components. The present report discusses the data required to determine the safe use of these types of ingredients, and provides advice on the development of risk assessment strategies consistent with due diligence under existing food regulations. Product specifications, composition and characterisation of standardised and authentic materials, documented history of use and comparison to existing products (taking into account the effect of industrial processing), description of the intended use and consequent exposure are highlighted as key background information on which to base a risk evaluation. The extent of experimental investigation required, such as in vitro, animal, and/or human studies, depends on the adequacy of this information. A decision tree is presented as an aid to determine the extent of data requirements based on product comparison. The ultimate safety in use depends on the establishment of an adequate safety margin between expected exposure and identified potential hazards. Health hazards may arise from inherent toxicities or contaminants of the plant materials, including the mechanism of the intended beneficial effect. A lower safety margin may therefore be expected than for food ingredients or additives where no physiological effects are intended. In rare cases, post launch monitoring programmes may be envisaged to confirm expected exposures and adequacy of the safety margin. This guidance document was elaborated by an expert group of the Natural Toxin Task Force of the European Branch of the International Life Sciences Institute--ILSI Europe and discussed with a wider audience of scientists at a workshop held on 13-15 May 2002 in Marseille, France.


Subject(s)
Dietary Supplements/adverse effects , Food Additives/adverse effects , Plant Preparations/adverse effects , Animals , Decision Trees , Diet , Dietary Supplements/standards , Food Additives/standards , Food Industry/standards , Humans , Plant Preparations/standards , Risk Assessment
12.
Diabetes Nutr Metab ; 16(2): 94-101, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12846448

ABSTRACT

BACKGROUND: Prevention of Type 1 diabetes mellitus (T1DM), a major childhood chronic disease with rapidly increasing incidence, is an urgent topic of research. We investigated whether 5% oligofructose (OF) as compared to 5% cellulose had a protective effect against diet-induced T1DM in the diabetes-prone BioBreeding (BB) rat model. METHODS: Groups of BB rats were fed the experimental diets from weaning. The diets were a cereal-based rodent diet (diabetogenic, positive control) and semi-synthetic rodent diets containing hydrolysed casein (non-diabetogenic, negative control), soy or whey as the sole protein source and 5% cellulose as fibre source. In additional groups fed soy and whey protein, the fibre source was 5% OF. T1DM incidence up to the age of 160 days was recorded applying biochemical and morphological criteria. Physiological effects of fibre were assessed through the analysis of biochemical parameters in plasma and of the protein/DNA ratio in intestinal mucosa. RESULTS: T1DM incidence was diet-dependent. Cereal-, soy- and whey-based diets were significantly more diabetogenic than the hydrolysed casein-based diet. Five per cent OF did not affect the incidence of T1DM induced by either soy or whey proteins as compared to cellulose, nor induce any of the biological effects attributed to a fermentable fibre. CONCLUSIONS: In the BB rat model, 5% OF in the diet did not have any protective effects against diet-induced T1DM. The present data do not suggest dietary OF as a promising approach for the dietary prevention of T1DM.


Subject(s)
Diabetes Mellitus, Type 1/prevention & control , Diet , Dietary Proteins/administration & dosage , Oligosaccharides/administration & dosage , Animals , Blood Glucose/analysis , Caseins/administration & dosage , Cellulose/administration & dosage , Diabetes Mellitus, Type 1/etiology , Diabetes Mellitus, Type 1/immunology , Diet/adverse effects , Disease Models, Animal , Female , Incidence , Intestinal Mucosa/pathology , Male , Rats , Rats, Inbred BB
13.
Biochem Biophys Res Commun ; 306(2): 488-95, 2003 Jun 27.
Article in English | MEDLINE | ID: mdl-12804590

ABSTRACT

The coffee-specific diterpenes cafestol and kahweol (C+K) have been identified as two important chemoprotective agents in coffee. In the present study, the potential preventive effects of C+K against the genotoxicity of B[a]P were investigated in rat primary hepatocytes and in human bronchial Beas-2B cells. Several independent mechanisms were identified and their respective contribution to the overall protective effects was determined. A marked dose-dependent inhibition by C+K of B[a]P DNA-binding was found in cells of both origins. However, data showed that the significant induction by C+K of the detoxifying enzyme GST-Yp subunit is the key mechanism of protection against B[a]P DNA-binding in rat liver. In contrast, the phase I-mediated mechanism where C+K produce an inhibition of CYP 1A1 induction by B[a]P is of key significance for the C+K protection in human Beas-2B cells. Moreover, this effect suggests a novel mechanism of chemoprotection by the coffee diterpenes cafestol and kahweol.


Subject(s)
Diterpenes/pharmacology , Animals , Benzo(a)pyrene , Blotting, Western , Cell Survival , Cells, Cultured , Coffee , Cytochrome P-450 CYP1A1/antagonists & inhibitors , Cytochrome P-450 CYP1A1/metabolism , DNA/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Ethacrynic Acid/pharmacology , Glutathione Transferase/metabolism , Humans , Rats , Rats, Sprague-Dawley , Time Factors , Tumor Cells, Cultured
14.
Food Chem Toxicol ; 40(8): 1155-63, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12067578

ABSTRACT

Epidemiological studies have found an inverse association between coffee consumption and the risk of certain types of cancers such as colorectal cancers. Animal data support such a chemopreventive effect of coffee. Substantial research has been devoted to the identification of coffee components that may be responsible for these beneficial effects. In animal models and cell culture systems, the coffee diterpenes cafestol and kahweol (C+K) were shown to produce a broad range of biochemical effects resulting in a reduction of the genotoxicity of several carcinogens including 7,12-dimethylbenz[a]anthracene (DMBA), aflatoxin B(1) (AFB(1)), benzo[a]pyrene (B[a]P) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Different mechanisms appear to be involved in these chemoprotective effects: an induction of conjugating enzymes (e.g. glutathione S-transferases, glucuronosyl S-transferases), an increased expression of proteins involved in cellular antioxidant defense (e.g. gamma-glutamyl cysteine synthetase and heme oxygenase-1) and an inhibition of the expression and/or activity of cytochromes P450 involved in carcinogen activation (e.g. CYP2C11, CYP3A2). In animal models, the C+K-mediated induction of conjugating and antioxidant enzymes has been observed in hepatic, intestinal and kidney tissues. In the small intestine, these inductions were shown to be mediated by Nrf2-dependent transcriptional activation. In vitro investigations obtained in cell cultures of human origin indicate that the effects and mechanisms observed in animal test systems with C+K are likely to be of relevance for humans. In human liver epithelial cell lines transfected to express AFB(1)-activating P450s, C+K treatment resulted in a reduction of AFB(1)-DNA binding. This protection was correlated with an induction of GST-mu, an enzyme known to be involved in AFB(1) detoxification. In addition, C+K was found to inhibit P450 2B6, one of the human enzymes responsible for AFB(1) activation. Altogether, the data on the biological effects of C+K provide a plausible hypothesis to explain some of the anticarcinogenic effects of coffee observed in human epidemiological studies and in animal experiments.


Subject(s)
Anticarcinogenic Agents/pharmacology , Coffee , Colorectal Neoplasms/prevention & control , Diterpenes/pharmacology , 9,10-Dimethyl-1,2-benzanthracene/metabolism , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Aflatoxin B1/metabolism , Aflatoxin B1/toxicity , Animals , Benzo(a)pyrene/metabolism , Benzo(a)pyrene/toxicity , Cells, Cultured , Coffee/chemistry , Disease Models, Animal , Enzyme Induction , Humans , Imidazoles/metabolism , Imidazoles/toxicity
15.
Food Chem Toxicol ; 39(6): 549-56, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11346484

ABSTRACT

The coffee-specific diterpenes cafestol and kahweol (C + K) have been reported to be anticarcinogenic in several animal models. Proposed mechanisms involve a co-ordinated modulation of several enzymes responsible for carcinogen detoxification, thus preventing reactive agents interacting with critical target sites. To address the human relevance of the chemoprotective effects of C + K against aflatoxin B(1) (AFB1) genotoxicity observed in rat liver, and to compare the mechanisms of protection involved in both species, animal and human hepatic in vitro test systems were applied. In rat primary hepatocytes, C + K reduced the expression of cytochrome P450 CYP 2C11 and CYP 3A2, the key enzymes responsible for AFB1 activation to the genotoxic metabolite aflatoxin B1-8,9 epoxide (AFBO). In addition, these diterpenes induced significantly GST Yc2, the most efficient rat GST subunit involved in AFBO detoxification. These effects of C + K resulted in a marked dose-dependent inhibition of AFB1-DNA binding in this rat in vitro culture system. Their relevance in humans was addressed using liver epithelial cell lines (THLE) stably transfected to express AFB1 metabolising cytochrome P450s. In these cells, C + K also produced a significant inhibition of AFB1-DNA adducts formation linked with an induction of the human glutathione S-transferase GST-mu. Altogether, these results suggest that C + K may have chemoprotective activity against AFB1 genotoxicity in both rats and humans.


Subject(s)
Aflatoxin B1/toxicity , Coffee/chemistry , Cytochrome P-450 Enzyme System/metabolism , Diterpenes/pharmacology , Liver/drug effects , Animals , Blotting, Western , Cells, Cultured , Chemoprevention , Cytochrome P-450 Enzyme System/genetics , DNA Adducts/drug effects , Dose-Response Relationship, Drug , Gene Expression Regulation, Enzymologic/drug effects , Hepatocytes/drug effects , Hepatocytes/enzymology , Humans , Liver/cytology , Liver/enzymology , Rats , Rats, Sprague-Dawley
16.
Free Radic Biol Med ; 30(10): 1089-98, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11369498

ABSTRACT

Ochratoxin A (OTA) is a mycotoxin found in some cereal and grain products. It is a potent renal carcinogen in male rats, although its mode of carcinogenic action is not known. Oxidative stress may play a role in OTA-induced toxicity and carcinogenicity. In this study, we measured several chemical and biological markers that are associated with oxidative stress response to determine if this process is involved in OTA-mediated toxicity in rats. Treatment of male rats with OTA (up to 2 mg/ 24 h exposure) did not increase the formation of biomarkers of oxidative damage such as the lipid peroxidation marker malondialdehyde in rat plasma, kidney, and liver, or the DNA damage marker 8-oxo-7,8-dihydro-2' deoxyguanosine in kidney DNA. However, OTA treatment (1 mg/kg) did result in a 22% decrease in alpha-tocopherol plasma levels and a 5-fold increase in the expression of the oxidative stress responsive protein haem oxygenase-1, specifically in the kidney. The selective alteration of these latter two markers indicates that OTA does evoke oxidative stress, which may contribute at least in part to OTA renal toxicity and carcinogenicity in rats during long-term exposure.


Subject(s)
Carcinogens/toxicity , Mycotoxins/toxicity , Nitrilotriacetic Acid/analogs & derivatives , Ochratoxins/toxicity , Oxidative Stress/drug effects , Animals , Blotting, Western , DNA Damage/drug effects , Ferric Compounds/toxicity , Guanosine/analogs & derivatives , Guanosine/metabolism , Heat-Shock Proteins/metabolism , Heme Oxygenase (Decyclizing)/metabolism , Kidney/drug effects , Kidney/enzymology , Kidney/metabolism , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Liver/metabolism , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Nitrilotriacetic Acid/toxicity , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley , Vitamin E/blood
17.
Neurotoxicology ; 21(4): 599-605, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11022867

ABSTRACT

Aggregating brain cell cultures of fetal rat telencephalon can be grown in a chemically defined medium for extended periods of time. After a phase of intense mitotic activity, these three-dimensional cell cultures undergo extensive morphological differentiation, including synaptogenesis and myelination. To study the developmental toxicity of organophosphorus compounds (OP), aggregating brain cell cultures were treated with parathion. Protein content and cell type-specific enzyme activities were not affected up to a concentration of 10(5) M. Gliosis, characterized by an increased staining for glial fibrillary acidic protein (GFAP), was observed in immature and in differentiated cells. In contrast, uridine incorporation and myelin basic protein (MBP) immunoreactivity revealed strong differences in sensitivity between these two developmental stages. These results are in agreement with the view that in vivo the development-dependent toxicity is not only due to changes in hepatic detoxification, but also to age-related modifications in the susceptibility of the different populations of brain cells. Furthermore, they underline the usefulness of histotypic culture systems with a high developmental potential, such as aggregating brain cell cultures, and stress the importance of applying a large range of criteria for testing the developmental toxicity of potential neurotoxicants.


Subject(s)
Brain/cytology , Insecticides/toxicity , Organophosphorus Compounds , Animals , Brain/drug effects , Cell Aggregation/drug effects , Cells, Cultured , Female , Humans , Pregnancy , Rats
18.
HNO ; 48(8): 589-97, 2000 Aug.
Article in German | MEDLINE | ID: mdl-10994170

ABSTRACT

A metaanalysis on pharmacological and psychological treatment reports was conducted in order to evaluate the overall effectiveness of these treatment conditions in chronic tinnitus. A totality of 109 treatment studies published between 1976 and 3/1995 and meeting minimal inclusion criteria was located, but only 24 studies reporting sufficient information could be analyzed. The methodological quality of the studies was evaluated by a coding scheme, and the resulting index of effectiveness has been weighted by this standard as well as by sample size. Effect sizes of pharmacological studies were ES = 1.27 and by this higher than the ones for psychological studies with ES = 0.88. This finding is attenuated by high (unspecific) placebo effects of ES = 0.65 in pharmacological studies compared to ES = 0.10 in psychological studies. In general, patients from psychological studies further improve after treatment in cases where catamnestic measurements have been conducted.


Subject(s)
Anesthetics, Local/therapeutic use , Psychotherapy , Psychotropic Drugs/therapeutic use , Tinnitus/therapy , Vasodilator Agents/therapeutic use , Anesthetics, Local/adverse effects , Combined Modality Therapy , Humans , Long-Term Care , Psychotropic Drugs/adverse effects , Randomized Controlled Trials as Topic , Tinnitus/psychology , Treatment Outcome , Vasodilator Agents/adverse effects
19.
J Pharmacol Exp Ther ; 294(3): 916-22, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10945841

ABSTRACT

Oxidative biotransformation, coupled with genetic variability in enzyme expression, has been the focus of hypotheses interrelating environmental and genetic factors in the etiology of central nervous system disease processes. Chemical modulation of cerebral cytochrome P450 (P450) monooxygenase expression character may be an important determinant of in situ metabolism, neuroendocrine homeostasis, and/or central nervous system toxicity resulting from exposure to neuroactive drugs and xenobiotic substances. To examine the capacity of the rat brain to undergo phenobarbital (PB)-mediated induction, we developed reverse transcription-polymerase chain reaction methods and evaluated the effects of several PB-like inducers on P450 and microsomal epoxide hydrolase gene expression. Animals treated i.p. with four daily doses of PB demonstrated markedly induced levels of CYP2B1, CYP2B2, and CYP3A1 mRNA in the striatum and cerebellum. In contrast, 1 or 2 days of PB treatment resulted in unchanged or even slightly decreased levels of CYP2B1 and CYP2B2 in the brain, although the latter treatments produced marked induction of the corresponding genes in the liver. Only slight increases in epoxide hydrolase RNA levels resulted in brains of PB-treated animals. Substantial activation of cerebral CYP2B1, CYP2B2, and CYP3A1 mRNA levels also resulted when animals were treated with the neuroactive drugs diphenylhydantoin and amitryptiline, and with the potential PB-like xenobiotic inducers trans-stilbene oxide and diallyl sulfide, whereas dichlorodiphenyltrichloroethane was less efficacious. Although the time course of the induction response is delayed in brain relative to that required for the liver, these results clearly establish that brain P450s are markedly PB inducible.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Brain/enzymology , Cytochrome P-450 Enzyme System/biosynthesis , Phenobarbital/pharmacology , RNA, Messenger/biosynthesis , Allyl Compounds/pharmacology , Amitriptyline/pharmacology , Animals , Blotting, Northern , Cytochrome P-450 CYP2B1/biosynthesis , Cytochrome P-450 CYP2B1/genetics , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/genetics , DDT/pharmacology , Enzyme Induction , Epoxide Hydrolases/genetics , Epoxide Hydrolases/metabolism , Liver/enzymology , Male , Mixed Function Oxygenases/biosynthesis , Mixed Function Oxygenases/genetics , Phenytoin/pharmacology , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Steroid Hydroxylases/biosynthesis , Steroid Hydroxylases/genetics , Stilbenes/pharmacology , Sulfides/pharmacology
20.
Toxicol Appl Pharmacol ; 165(3): 175-83, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10873710

ABSTRACT

An in vitro model, the aggregating brain cell culture of fetal rat telencephalon, has been used to study the maturation-dependent sensitivity of brain cells to two organophosphorus pesticides (OPs), chlorpyrifos and parathion, and to their oxon derivatives. Immature (DIV 5-15) or differentiated (DIV 25-35) brain cells were treated continuously for 10 days. Acetylcholinesterase (AChE) inhibitory potency for the OPs was compared to that of eserine (physostigmine), a reversible AChE inhibitor. Oxon derivatives were more potent AChE inhibitors than the parent compounds, and parathion was more potent than chlorpyrifos. No maturation-dependent differences for AChE inhibition were found for chlorpyrifos and eserine, whereas for parathion and paraoxon there was a tendency to be more effective in immature cultures, while the opposite was true for chlorpyrifos-oxon. Toxic effects, assessed by measuring protein content as an index of general cytotoxicity, and various enzyme activities as cell-type-specific neuronal and glial markers (ChAT and GAD, for cholinergic and GABAergic neurons, respectively, and GS and CNP, for astrocytes and oligodendrocytes, respectively) were only found at more than 70% of AChE inhibition. Immature compared to differentiated cholinergic neurons appeared to be more sensitive to OP treatments. The oxon derivates were found to be more toxic on neurons than the parent compounds, and chlorpyrifos was more toxic than parathion. Eserine was not neurotoxic. These results indicate that inhibition of AChE remains the most sensitive macromolecular target of OP exposure, since toxic effects were found at concentrations in which AChE was inhibited. Furthermore, the compound-specific reactions, the differential pattern of toxicity of OPs compared to eserine, and the higher sensitivity of immature brain cells suggest that the toxic effects and inhibition of AChE are unrelated.


Subject(s)
Cell Differentiation/drug effects , Chlorpyrifos/pharmacology , Cholinesterase Inhibitors/pharmacology , Parathion/pharmacology , Phosphoric Diester Hydrolases , Telencephalon/drug effects , 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , Animals , Biomarkers , Cell Differentiation/physiology , Cells, Cultured , Chlorpyrifos/analogs & derivatives , Choline O-Acetyltransferase/metabolism , Dose-Response Relationship, Drug , Embryonic and Fetal Development , Glutamate Decarboxylase/metabolism , Glutamate-Ammonia Ligase/metabolism , Neuroglia/drug effects , Neuroglia/enzymology , Neurons/drug effects , Neurons/enzymology , Paraoxon/pharmacology , Parathion/analogs & derivatives , Physostigmine/pharmacology , Rats , Telencephalon/cytology , Telencephalon/embryology , Telencephalon/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...